Andrew Kovalenko

4.2k total citations · 1 hit paper
30 papers, 3.4k citations indexed

About

Andrew Kovalenko is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Andrew Kovalenko has authored 30 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Andrew Kovalenko's work include Cell death mechanisms and regulation (16 papers), interferon and immune responses (8 papers) and Inflammasome and immune disorders (8 papers). Andrew Kovalenko is often cited by papers focused on Cell death mechanisms and regulation (16 papers), interferon and immune responses (8 papers) and Inflammasome and immune disorders (8 papers). Andrew Kovalenko collaborates with scholars based in Israel, South Korea and United States. Andrew Kovalenko's co-authors include David Wallach, Giuseppina Cantarella, Tae‐Bong Kang, Konstantin Bogdanov, Alain Israël, Christine Chable-Bessia, Gilles Courtois, Seung‐Hoon Yang, Seongmin Yoon and Beáta Tóth and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Andrew Kovalenko

30 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination

2003 830 citations Andrew Kovalenko, Christine Chable-Bessia et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Kovalenko Israel	20	2.4k	1.8k	1.1k	529	365	30	3.4k
Nicolas Bidère France	26	2.0k 0.8×	1.4k 0.8×	798 0.7×	484 0.9×	354 1.0×	59	3.3k
Jessie Xiong United States	8	2.0k 0.8×	1.7k 1.0×	1.5k 1.3×	728 1.4×	271 0.7×	12	3.5k
Taoyong Chen China	36	1.8k 0.7×	1.7k 1.0×	623 0.6×	507 1.0×	230 0.6×	55	3.4k
Wen-Chen Yeh Canada	23	1.7k 0.7×	2.8k 1.6×	1.3k 1.2×	656 1.2×	482 1.3×	25	4.2k
Ueli Nachbur Australia	23	1.7k 0.7×	1.2k 0.7×	597 0.5×	415 0.8×	488 1.3×	34	2.5k
Tanya Goncharov Israel	7	2.8k 1.1×	1.2k 0.7×	628 0.6×	623 1.2×	444 1.2×	7	3.3k
Leonard B. Maggi United States	22	1.9k 0.8×	1.3k 0.7×	633 0.6×	699 1.3×	294 0.8×	38	3.2k
Daryl T. Baldwin United States	9	2.5k 1.1×	2.0k 1.2×	915 0.8×	824 1.6×	438 1.2×	10	3.9k
Joseph Barbi United States	24	1.3k 0.5×	1.5k 0.8×	821 0.7×	619 1.2×	392 1.1×	53	3.4k
Jacqueline W. Pierce United States	14	1.9k 0.8×	1.1k 0.6×	970 0.9×	632 1.2×	264 0.7×	17	3.1k

Countries citing papers authored by Andrew Kovalenko

Since Specialization

Citations

This map shows the geographic impact of Andrew Kovalenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Kovalenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Kovalenko more than expected).

Fields of papers citing papers by Andrew Kovalenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Kovalenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Kovalenko. The network helps show where Andrew Kovalenko may publish in the future.

Co-authorship network of co-authors of Andrew Kovalenko

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Kovalenko. A scholar is included among the top collaborators of Andrew Kovalenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Kovalenko. Andrew Kovalenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gokhman, Irena, Rebecca Haffner‐Krausz, Ester Feldmesser, et al.. (2023). Kinesin family member 2A gates nociception. Cell Reports. 42(10). 113257–113257. 2 indexed citations

Kang, Tae‐Bong, et al.. (2018). Caspase-8 deficiency in mouse embryos triggers chronic RIPK1-dependent activation of inflammatory genes, independently of RIPK3. Cell Death and Differentiation. 25(6). 1107–1117. 30 indexed citations

Yoon, Seongmin, Andrew Kovalenko, Konstantin Bogdanov, & David Wallach. (2017). MLKL, the Protein that Mediates Necroptosis, Also Regulates Endosomal Trafficking and Extracellular Vesicle Generation. Immunity. 47(1). 51–65.e7. 287 indexed citations

Yoon, Sang-Wook, Konstantin Bogdanov, Andrew Kovalenko, & David Wallach. (2015). Necroptosis is preceded by nuclear translocation of the signaling proteins that induce it. Cell Death and Differentiation. 23(2). 253–260. 122 indexed citations

Kang, Tae‐Bong, Seung‐Hoon Yang, Beáta B. Tóth, Andrew Kovalenko, & David Wallach. (2014). Activation of the NLRP3 Inflammasome by Proteins That Signal for Necroptosis. Methods in enzymology on CD-ROM/Methods in enzymology. 545. 67–81. 40 indexed citations

Wallach, David, Tae‐Bong Kang, Seung‐Hoon Yang, & Andrew Kovalenko. (2013). The in vivo significance of necroptosis: Lessons from exploration of caspase-8 function. Cytokine & Growth Factor Reviews. 25(2). 157–165. 14 indexed citations

Wallach, David, Tae‐Bong Kang, & Andrew Kovalenko. (2013). Concepts of tissue injury and cell death in inflammation: a historical perspective. Nature reviews. Immunology. 14(1). 51–59. 203 indexed citations

Kang, Tae‐Bong, Seung‐Hoon Yang, Beáta Tóth, Andrew Kovalenko, & David Wallach. (2012). Caspase-8 Blocks Kinase RIPK3-Mediated Activation of the NLRP3 Inflammasome. Immunity. 38(1). 27–40. 352 indexed citations

Rajput, Akhil, Andrew Kovalenko, Konstantin Bogdanov, et al.. (2011). RIG-I RNA Helicase Activation of IRF3 Transcription Factor Is Negatively Regulated by Caspase-8-Mediated Cleavage of the RIP1 Protein. Immunity. 34(3). 340–351. 161 indexed citations

10.

Wallach, David, Andrew Kovalenko, & Tae‐Bong Kang. (2011). ‘Necrosome’-induced inflammation: must cells die for it?. Trends in Immunology. 32(11). 505–509. 34 indexed citations

11.

Wallach, David, Tae‐Bong Kang, Akhil Rajput, et al.. (2010). Anti‐inflammatory functions of the “apoptotic” caspases. Annals of the New York Academy of Sciences. 1209(1). 17–22. 8 indexed citations

12.

Wallach, David & Andrew Kovalenko. (2009). 12th international TNF conference: The good, the bad and the scientists. Cytokine & Growth Factor Reviews. 20(4). 259–269. 5 indexed citations

13.

Kang, Tae‐Bong, Gi‐Su Oh, Elke Scandella, et al.. (2008). Mutation of a Self-Processing Site in Caspase-8 Compromises Its Apoptotic but Not Its Nonapoptotic Functions in Bacterial Artificial Chromosome-Transgenic Mice. The Journal of Immunology. 181(4). 2522–2532. 103 indexed citations

14.

Kang, Tae‐Bong, Andrew Kovalenko, Hila Barash, et al.. (2008). Cell-autonomous and non-cell-autonomous functions of caspase-8. Cytokine & Growth Factor Reviews. 19(3-4). 209–217. 10 indexed citations

15.

Krelin, Yakov, et al.. (2008). Caspase-8 deficiency facilitates cellular transformation in vitro. Cell Death and Differentiation. 15(9). 1350–1355. 47 indexed citations

16.

Kovalenko, Andrew & David Wallach. (2006). If the Prophet Does Not Come to the Mountain: Dynamics of Signaling Complexes in NF-κB Activation. Molecular Cell. 22(4). 433–436. 32 indexed citations

17.

Kovalenko, Andrew, Christine Chable-Bessia, Giuseppina Cantarella, et al.. (2003). The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature. 424(6950). 801–805. 830 indexed citations breakdown →

18.

Wallach, David, Thangavelu U. Arumugam, Mark Boldin, et al.. (2002). How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-kappaB activation by members of the TNF/NGF receptor family.. Arthritis Research. 4(Suppl 3). S189–S189. 40 indexed citations

19.

Kovalenko, Andrew, et al.. (2000). Recruitment of the IKK Signalosome to the p55 TNF Receptor. Immunity. 12(3). 301–311. 390 indexed citations

20.

Kovalenko, Andrew, et al.. (1997). CASH, a Novel Caspase Homologue with Death Effector Domains. Journal of Biological Chemistry. 272(32). 19641–19644. 266 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact